GO ID | GO:0007179 |
Ontology | BP |
GO Term | transforming growth factor beta receptor signaling pathway |
Definition | A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
MSTN |
myostatin |
2660 |
O14793 |
chr2: 190,055,697-190,062,729 |
SMAD7 |
SMAD family member 7 |
4092 |
O15105 |
chr18: 48,919,853-48,950,711 |
SMAD9 |
SMAD family member 9 |
4093 |
O15198 |
chr13: 36,844,831-36,920,765 |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
6885 |
O43318 |
chr6: 90,513,573-90,587,045 |
SMAD6 |
SMAD family member 6 |
4091 |
O43541 |
chr15: 66,702,228-66,782,848 |
GDF9 |
growth differentiation factor 9 |
2661 |
O60383 |
chr5: 132,861,181-132,866,884 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
FSHB |
follicle stimulating hormone, beta polypeptide |
2488 |
P01225 |
chr11: 30,231,016-30,235,261 |
COL3A1 |
collagen, type III, alpha 1 |
1281 |
P02461 |
chr2: 188,974,320-189,012,746 |
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
COL1A2 |
collagen, type I, alpha 2 |
1278 |
P08123 |
chr7: 94,394,561-94,431,232 |
PARP1 |
poly(ADP-ribose) polymerase 1 |
142 |
P09874 |
chr1: 226,360,691-226,408,079 |
FURIN |
furin (paired basic amino acid cleaving enzyme) |
5045 |
P09958 |
chr15: 90,868,592-90,883,458 |
UBC |
ubiquitin C |
7316 |
P0CG48 |
chr12: 124,911,604-124,917,368 |
SKI |
SKI proto-oncogene |
6497 |
P12755 |
chr1: 2,228,695-2,310,119 |
SKIL |
SKI-like proto-oncogene |
6498 |
P12757 |
chr3: 170,357,678-170,396,835 |
CCL2 |
chemokine (C-C motif) ligand 2 |
6347 |
P13500 |
chr17: 34,255,218-34,257,203 |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
3248 |
P15428 |
chr4: 174,490,177-174,523,154 |
CREB1 |
cAMP responsive element binding protein 1 |
1385 |
P16220 |
chr2: 207,529,737-207,603,431 |
ITGB5 |
integrin subunit beta 5 |
3693 |
P18084 |
chr3: 124,761,948-124,901,418 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
1003 |
P33151 |
chr16: 66,366,622-66,404,786 |
BMPR1A |
bone morphogenetic protein receptor type IA |
657 |
P36894 |
chr10: 86,756,601-86,932,838 |
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
3397 |
P41134 |
chr20: 31,605,283-31,606,515 |
GDF5 |
growth differentiation factor 5 |
8200 |
P43026 |
chr20: 35,433,347-35,454,746 |
UBE2M |
ubiquitin conjugating enzyme E2M |
9040 |
P61081 |
chr19: 58,555,712-58,558,960 |
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
RPS27A |
ribosomal protein S27a |
6233 |
P62979 |
chr2: 55,231,903-55,235,853 |
UBA52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
7311 |
P62987 |
chr19: 18,571,730-18,577,550 |
SMAD3 |
SMAD family member 3 |
4088 |
P84022 |
chr15: 67,063,763-67,195,195 |
TGFBR3 |
transforming growth factor beta receptor III |
7049 |
Q03167 |
chr1: 91,680,343-91,906,335 |
ACVR1 |
activin A receptor type I |
90 |
Q04771 |
chr2: 157,736,444-157,875,862 |
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
KLF10 |
Kruppel-like factor 10 |
7071 |
Q13118 |
chr8: 102,648,779-102,655,902 |
BAMBI |
BMP and activin membrane-bound inhibitor |
25805 |
Q13145 |
chr10: 28,677,342-28,682,939 |
ADAM9 |
ADAM metallopeptidase domain 9 |
8754 |
Q13443 |
chr8: 38,996,869-39,105,144 |
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
5796 |
Q15262 |
chr6: 127,968,779-128,520,674 |
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
10454 |
Q15750 |
chr22: 39,399,741-39,437,060 |
SMAD2 |
SMAD family member 2 |
4087 |
Q15796 |
chr18: 47,808,957-47,931,146 |
SMAD1 |
SMAD family member 1 |
4086 |
Q15797 |
chr4: 145,481,194-145,558,079 |
NEDD8 |
neural precursor cell expressed, developmentally down-regulated 8 |
4738 |
Q15843 |
chr14: 24,216,852-24,232,454 |
ZYX |
zyxin |
7791 |
Q15942 |
chr7: 143,381,080-143,391,111 |
AMHR2 |
anti-Mullerian hormone receptor, type II |
269 |
Q16671 |
chr12: 53,423,855-53,431,534 |
GCNT2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
2651 |
Q8N0V5 |
chr6: 10,492,223-10,629,368 |
PARD3 |
par-3 family cell polarity regulator |
56288 |
Q8TEW0 |
chr10: 34,109,560-34,815,325 |
SMAD5 |
SMAD family member 5 |
4090 |
Q99717 |
chr5: 136,132,845-136,188,747 |
CITED1 |
Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1 |
4435 |
Q99966 |
chrX: 72,301,638-72,307,187 |
GDF15 |
growth differentiation factor 15 |
9518 |
Q99988 |
chr19: 18,374,731-18,389,176 |
FUT8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
2530 |
Q9BYC5 |
chr14: 65,410,592-65,744,121 |
HIPK2 |
homeodomain interacting protein kinase 2 |
28996 |
Q9H2X6 |
chr7: 139,561,570-139,777,778 |
PARD6A |
par-6 family cell polarity regulator alpha |
50855 |
Q9NPB6 |
chr16: 67,660,946-67,662,778 |
DUSP22 |
dual specificity phosphatase 22 |
56940 |
Q9NRW4 |
chr6: 291,630-351,355 |
MTMR4 |
myotubularin related protein 4 |
9110 |
Q9NYA4 |
chr17: 58,489,529-58,517,905 |
NLK |
nemo-like kinase |
51701 |
Q9UBE8 |
chr17: 28,041,737-28,196,381 |
USP15 |
ubiquitin specific peptidase 15 |
9958 |
Q9Y4E8 |
chr12: 62,260,338-62,417,431 |
F11R |
F11 receptor |
50848 |
Q9Y624 |
chr1: 160,995,211-161,021,348 |